Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/08/2776205/0/en/Nuvectis-Pharma-Inc-Reports-Third-Quarter-2023-Financial-Results-and-Business-Highlights.html

FORT LEE, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ:NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today reported its financial results for the third quarter 2023 and provided an update on recent business progress.

Read more at globenewswire.com

Related news for (NVCT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.